Application no. and date | 16783855.6 (espacenet) (Federated) (European Patent Register), 20160421 | Patent/reg. no. and date | DK/EP 3285768, 20201230 | Publication date | 20180228 | Priority no. and date | US 201562150721 P, 20150421, US 201562153815 P, 20150428 | EP pub. no. and date |
EP 3285768 20180228 | Effective date | | Applicant/owner | Eiger Biopharmaceuticals, Inc., 2155 Park Boulevard
Palo Alto, CA 94306, US | Applicant ref. no. | V2101-018-DK | Inventor | GOSSELIN, Patrick, c/o Eiger Biopharmaceuticals, Inc. 2155 Park Boulevard
Palo Alto, CA 94306, US, BETANCOURT, Aimesther, c/o Eiger Biopharmaceuticals, Inc. 2155 Park Boulevard
Palo Alto, CA 94306, US | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | Opponent | | IPC Class | A61K 31/427 (2006.01) , A61K 31/4545 (2006.01) , A61K 47/32 (2006.01) , A61K 47/38 (2006.01) , A61K 9/14 (2006.01) , A61P 31/14 (2006.01) | Title | FARMACEUTISKE SAMMENSÆTNINGER OMFATTENDE LONAFARNIB OG RITONAVIR | Int. application no. | US2016028651 | Int. publication no. | WO2016172342 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|